Asia Pacific Orthopedic Biometrial Market Share

Asia Pacific Orthopedic Biomaterial Market Scenario

The Orthopedic Biomaterial Market of asia pacific is expected to reach USD 40,519.52 million by 2030 at 10.5% CAGR during the forecast period 2022-2030. Orthopedic biomaterials are organic or synthetic materials used for the treatment of internal fractures. During the last decade different new techniques and materials are introduced for orthopedic implants and surgeries and biomaterials have found a vital role in it. These biomaterials are used in manufacturing of different implants since they do not evoke any immunological reactions with the body, which makes it a first choice for manufacturing of implants. Increasing demand for the orthopedic biomaterial because of its application in knee and hip replacement surgeries, and increasing incident of medical emergencies drive the Asia Pacific orthopedic biomaterial market.

Introduction of novel implants of titanium has increased the success rate of implant surgeries and also contributed to the growth of the orthopedic market in Asia Pacific. Moreover, increasing number of orthopedic surgeries, increasing aging population, and growing governmental support also drive the Asia Pacific market. However, increasing failure in joints implants, stringent regulatory laws, and high cost of treatment may hinder the growth of Asia Pacific orthopedic biomaterial market during the review period.

Orthopedic biomaterials might be artificial or natural. They are made to be inserted into a person's body as parts of machines that are intended to carry out certain biological tasks by replacing or mending various tissues. Orthopedic biomaterials are utilized for tissue fixation, spine implants, joint replacements, and other orthopedic procedures. Additionally, the need for next-generation orthopedic biomaterials specifically designed to fulfill the requirements of a particular orthopedic operation is on the rise globally. On the other hand, the market's expansion has been hampered by the restricted payment coverage alternatives for these devices and the falling reimbursement for orthopedic implants in several nations. Additionally, the lack of rebates has forced suppliers to reduce the cost of these products, which has slowed market expansion.

The growing geriatric population, rising incidence rates of accidents and sports-related injuries, rising awareness of orthopedic biomaterials, and introduction of novel products by major market players are a few of the factors anticipated to boost market growth over the forecast period. Fewer traffic accidents and injuries occurred due to the pandemic's widespread lockdowns, curtailing private and public transit. As a result, the focus of healthcare institutions shifted from operations to COVID-19 patients. This immediately affected the market during the early pandemic phase, especially in specialist hospitals. Increased bone fractures, disc degenerative disorders, and more trauma cases are predicted to increase product demand in this market. Due to factors like the rising geriatric population, increasing incidence rates of accidents and sports-related injuries, and rising awareness of orthopedic biomaterials.

CitrefixTM, a suture anchor system for surgical procedures on the foot and ankle, was introduced by Stryker. The new technology uses CitregenTM, a highly acclaimed bioresorbable substance created to imitate the composition and structure of natural bone. Citrefix is a resorbable, bio-inspired suture anchor system for single-use sutures. Citregen, an elastomeric substance formed from a citrate polymer and specifically created to imitate bone chemistry for regulated resorption without persistent inflammation, is used in its construction. These special chemical and mechanical qualities are intended to promote healthy bone growth and heal transplanted tissue when used in orthopedic surgical procedures.

Key PlayersSome of the major players in Asia Pacific orthopedic biomaterial market: Kyocera Corporation (Japan), Materion Corporation (US), S&V Technologies (Germany), Rayner (UK), InVision Biomedical (US), Covestro (Germany), Invibio Ltd. (U.K.), Royal DSM (Netherlands), BASF SE (Germany), Corbion N.V. (Netherlands), CeramTec (Germany), Tianjin Walkman Biomaterial Co. (China), Kanghui Holdings (China), Johnson & Johnson Services, Inc. (US), Cam Bioceramics B.V. (Netherland), and Xian Airfoil Technology Co (China).SegmentationThe orthopedic biomaterials market is segmented on the basis of types of material, applications, and end users. On the basis of types of material, the market is segmented into metals and non-metals.  The metals are further segmented into stainless steel, titanium alloy, cobalt alloy, and others. Non-metal are further segmented into ceramic, polymeric, natural biomaterials, and others. The ceramic are sub-segmented into alumina, calcium phosphate, zirconium dioxide, carbon, and others. The polymeric materials are sub-segmented into polymethylmethacrylate (PMMA), polyethylene, silicone, polyester, and other. The natural biomaterials are sub-segmented into collagen, chitin & chitosan, and other

On the basis of applications, the Asia Pacific orthopedic biomaterial market is segmented into joint replacement, fracture fixation devices, tissue fixation, spine implants, viscosupplementation, and other. Joint replacement is sub-segmented into hip replacement, knee replacement, shoulder and elbow replacement, and other. Tissue fixation is sub-segmented into interference screws, suture anchors, and others. Spine implants are further sub-segmented into spine fusion and other. The fracture fixation devices are sub segmented into screws, plates for bones, rods, and other.

On the basis of end users, the Asia Pacific orthopedic biomaterial market is segmented into hospital, clinics, and others.The first surgical application of Acuitive Technologies, Inc.'s (Acuitive) Citrelock® ACL Tendon Fixation Device was disclosed. The novel ACL device offers orthopedic surgeons a unique design thanks to a tendon-friendly spiral thread made of Citregen, a next-generation resorbable material with special molecular and mechanical characteristics. With its cutting-edge material technology and distinctive design, the Citrelock ACL Tendon Fixation Device contributes to meeting this therapeutic requirement. The Citrelock ACL System is an exciting new addition to Acuitive's line of products and the first of many that we will be releasing with an emphasis on the sports medicine sector.

Regional AnalysisChina dominates the Asia Pacific orthopedic biomaterial market owing to increasing prevalence of different orthopedic surgeries in China. Increasing awareness of biodegradable products among the people, rapid research and development and huge aging population in this region have added fuel to the growth of the market. Japan and Australia are other major contributor of the Asia Pacific orthopedic biomaterial market in this region. 

Intended Audience

• Product manufacturers


• Biomaterial manufacturer


• Research and development (R&D) companies


• Hospitals and laboratories


• Medical research laboratories


• Academic medical institutes and universities